Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Teva-Pharmaceuticals
Company Monitoring Page for Teva-Pharmaceuticals
latest headlines for company on cafepharma
Teva’s MS Treatment Copaxone Chalks Up 25% Sales Gain
WSJ Online
Wed, 02/17/10 - 09:01 am
Tags:
Teva Pharmaceuticals
,
Copaxone
,
MS
,
multiple sclerosis
Teva, Actavis Said to Be Final Ratiopharm Bidders as EQT Exits
Bloomberg
Wed, 02/17/10 - 08:56 am
Tags:
Teva Pharmaceuticals
,
Ratiopharm
,
M&A
,
Actavis
Teva swings to profit; adjusted net up 18%
Marketwatch
Tue, 02/16/10 - 09:32 am
Tags:
Teva Pharmaceuticals
,
earnings
Teva and Novartis reach settlement on Famvir suit
Marketwatch
Tue, 02/16/10 - 09:29 am
Tags:
Teva Pharmaceuticals
,
Novartis
,
lawsuits
,
settlements
,
Famvir
Pharmas Walking the Patent Tightrope
Seeking Alpha
Tue, 02/16/10 - 09:26 am
Tags:
Alzheimer's disease
,
Teva Pharmaceuticals
,
Janssen Pharmaceuticals
,
Eli Lilly
,
patents
,
Actavis
Is Pfizer still in the Ratiopharm race?
Fierce Pharma
Thu, 02/11/10 - 12:19 pm
Tags:
Ratiopharm
,
Pfizer
,
M&A
,
Actavis
,
Teva Pharmaceuticals
Rexahn: The Undiscovered Biotech
Seeking Alpha
Wed, 02/10/10 - 10:42 am
Tags:
Rexahn
,
Teva Pharmaceuticals
,
Pfizer
,
Eli Lilly
,
GSK
Teva, Active extend pact on oral MS therapy
Marketwatch
Mon, 02/8/10 - 11:36 am
Tags:
Teva Pharmaceuticals
,
Active Biotech
,
partnerships
,
MS
,
multiple sclerosis
Broker comments lift pharma stocks
FT.com
Mon, 02/8/10 - 10:16 am
Tags:
drug stocks
,
Teva Pharmaceuticals
,
GSK
,
Pfizer
,
Shire
,
UCB Pharmaceuticals
,
Merck KGaA
Teva allocates $315m for Medicaid settlement
Globes, Israel
Sun, 02/7/10 - 11:44 am
Tags:
Teva Pharmaceuticals
Teva’s Needle-Free Tjet® Device Takes a Kid-Friendly Approach to Growth Hormone Deficiency Treatment
Health News Digest
Sat, 02/6/10 - 01:03 pm
Tags:
Teva Pharmaceuticals
,
growth hormone deficiency
Teva Pharma settles some Medicaid drug price suits
Yahoo/AP
Fri, 02/5/10 - 10:27 am
Tags:
Medicaid
,
drug pricing
,
lawsuits
,
Teva Pharmaceuticals
,
settlements
Earnings Growth Proves Drugmaker Made Right Moves
Yahoo/AP
Fri, 02/5/10 - 09:53 am
Tags:
earnings
,
Merck KGaA
,
Mylan
,
Teva Pharmaceuticals
,
Sandoz
,
Novartis
Teva, Amgen Duke It Out Over Generic Biotech
WSJ Online
Wed, 02/3/10 - 10:19 am
Tags:
generics
,
Amgen
,
Teva Pharmaceuticals
Pfizer aims for No. 1 in Japanese generics
Fierce Pharma
Mon, 02/1/10 - 11:26 am
Tags:
Pfizer
,
generics
,
Japan
,
Teva Pharmaceuticals
Merck, Pfizer Overcharged New York for Medicines, Judge Rules
Bloomberg
Fri, 01/29/10 - 08:47 am
Tags:
New York
,
Merck
,
Pfizer
,
Novartis
,
Mylan
,
Teva Pharmaceuticals
,
drug pricing
,
AWP
Nice, Novartis, Very Nice
Motley Fool
Wed, 01/27/10 - 09:50 pm
Tags:
Novartis
,
Teva Pharmaceuticals
,
Alcon
There's Nothing Generic About the Profits
Investopedia
Wed, 01/27/10 - 10:54 am
Tags:
generics
,
Pfizer
,
Bristol-Myers Squibb
,
Sanofi
,
Novartis
,
Teva Pharmaceuticals
,
Watson Pharmaceuticals
Teva Moves Ahead in Brain Drug Battle
Forbes
Tue, 01/26/10 - 05:54 pm
Tags:
Teva Pharmaceuticals
,
Merck
,
Temodar
,
cancer
Teva Pharmaceuticals is the latest defendant in an Abbott Laboratories patent suit
Forbes
Tue, 01/26/10 - 07:19 am
Tags:
Abbott Laboratories
,
Teva Pharmaceuticals
,
lawsuits
,
Simcor
,
generics
Pages
« first
‹ previous
…
30
31
32
33
34
35
36
37
38
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.